Chronic paroxetine increases [3H]nociceptin binding in rat dorsal raphe nucleus

Neuroreport
Catherine VilpouxI Leroux-Nicollet

Abstract

Opioid-receptor-like I (ORLI) receptors, ORLI mRNA and nociceptin are particularly abundant in the limbic system and in central monoaminergic areas, brain regions involved in mood regulation and response to antidepressants. To analyse whether ORLI receptors adaptations occur during the first 3 weeks of an antidepressant treatment, we administered paroxetine to rats (10 mg/kg, i.p., once a day) for 4, 7,14 or 21 days. A significant increase (22-50%) in [3H]nociceptin binding sites density appeared specifically in the dorsal raphe nucleus after 4, 7 or 21 days of treatment, whereas no change was observed at any time in any other brain regions studied. These data constitute the first evidence of a modulation of ORLI receptors by an antidepressant treatment.

References

Aug 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·E Le PoulL Lanfumey
Feb 1, 1994·Journal of Clinical Psychopharmacology·L E Hollister
Apr 29, 1996·The Journal of Comparative Neurology·B AntonC J Evans
Dec 1, 1996·British Journal of Pharmacology·M ConnorM J Christie
Mar 24, 1998·Annual Review of Medicine·W C Drevets
Jun 4, 1998·Trends in Neurosciences·T DarlandD K Grandy
Nov 24, 1998·Naunyn-Schmiedeberg's Archives of Pharmacology·E SchlickerU Bauer
Sep 28, 1999·British Journal of Pharmacology·A SiniscalchiC Bianchi
Feb 17, 2000·Neurochemistry International·C Davidson, J A Stamford
Apr 1, 2000·British Journal of Pharmacology·G Calo'D Regoli
Sep 22, 2000·Peptides·C Mollereau, L Mouledous

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.